These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9137530)

  • 1. Quantification of 4-hydroxyifosfamide in plasma of ifosfamide-treated mice.
    Struck RF; McCain DM; Tendian SW; Tillery KH
    Cancer Chemother Pharmacol; 1997; 40(1):57-9. PubMed ID: 9137530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamide.
    Bryant BM; Jarman M; Baker MH; Smith IE; Smyth JF
    Cancer Res; 1980 Dec; 40(12):4734-8. PubMed ID: 7438105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
    Huang Z; Waxman DJ
    Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of 4-hydroxyifosfamide concomitantly with ifosfamide and its dechloroethylated metabolites using gas chromatography and a nitrogen phosphorus-selective detector.
    Gourmel B; Granvil CP; Denis SL; Wainer IW; Bousquet B
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(1):3-15. PubMed ID: 10517217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ifosfamide, 4-hydroxyifosfamide, N2-dechloroethylifosfamide, N3-dechloroethylifosfamide and iphosphoramide mustard in plasma by gas chromatography-mass spectrometry.
    Wang JJ; Chan KK
    J Chromatogr B Biomed Appl; 1995 Dec; 674(2):205-17. PubMed ID: 8788150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
    Storme T; Deroussent A; Mercier L; Prost E; Re M; Munier F; Martens T; Bourget P; Vassal G; Royer J; Paci A
    J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.
    Dirven HA; Megens L; Oudshoorn MJ; Dingemanse MA; van Ommen B; van Bladeren PJ
    Chem Res Toxicol; 1995; 8(7):979-86. PubMed ID: 8555414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ifosfamide and some metabolites in children.
    Kaijser GP; De Kraker J; Bult A; Underberg WJ; Beijnen JH
    Anticancer Res; 1998; 18(3B):1941-9. PubMed ID: 9677448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography.
    Kaijser GP; Ter Riet PG; de Kraker J; Bult A; Beijnen JH; Underberg WJ
    J Pharm Biomed Anal; 1997 Mar; 15(6):773-81. PubMed ID: 9172103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide.
    Preiss R; Schmidt R; Baumann F; Hanschmann H; Hauss J; Geissler F; Pahlig H; Ratzewiss B
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):385-92. PubMed ID: 12136253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated oxazaphosphorines are transported predominantly by erythrocytes.
    Highley MS; Schrijvers D; Van Oosterom AT; Harper PG; Momerency G; Van Cauwenberghe K; Maes RA; De Bruijn EA; Edelstein MB
    Ann Oncol; 1997 Nov; 8(11):1139-44. PubMed ID: 9426334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamide.
    Struck RF; Davis RL; Berardini MD; Loechler EL
    Cancer Chemother Pharmacol; 2000; 45(1):59-62. PubMed ID: 10647503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
    Lu H; Wang JJ; Chan KK; Young D
    Drug Metab Dispos; 1998 May; 26(5):476-82. PubMed ID: 9571229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal clearance of ifosfamide.
    Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
    Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to the study of ifosfamide metabolism by the analysis of human body fluids with 31P nuclear magnetic resonance spectroscopy.
    Martino R; Crasnier F; Chouini-Lalanne N; Gilard V; Niemeyer U; De Forni M; Malet-Martino MC
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1133-44. PubMed ID: 1545382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excretion kinetics of ifosfamide side-chain metabolites in children on continuous and short-term infusion.
    Silies H; Blaschke G; Hohenlöchter B; Rossi R; Jürgens H; Boos J
    Int J Clin Pharmacol Ther; 1998 May; 36(5):246-52. PubMed ID: 9629987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of enantiomers of the cytostatic ifosfamide].
    Blaschke G; Widey W
    Arzneimittelforschung; 1989 Feb; 39(2):223-6. PubMed ID: 2730691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of dimethyl-ifosfamide and its N-deschloropropylated metabolites in mouse plasma by liquid chromatography-tandem mass spectrometry.
    Deroussent A; Rodriguez S; Martelli S; Seck A; Dubus-Daudigeos E; Desmaële D; Vassal G; Paci A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):743-50. PubMed ID: 21377940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamide.
    Kaijser GP; Keizer HJ; Beijnen JH; Bult A; Underberg WJ
    Anticancer Res; 1996; 16(5B):3247-57. PubMed ID: 8920799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.